If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Rezvoglar ™ (insulin glargine-aglr) injection
3 mL (100 units/mL)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is the structure of Rezvoglar™ (insulin glargine‑aglr) and Basaglar® (insulin glargine) the same?
Rezvoglar has an identical amino acid sequence to that of Basaglar.
Structure of Rezvoglar
Rezvoglar™ (insulin glargine-aglr) 100 units/mL and Basaglar® (insulin glargine) 100 units/mL have an identical amino acid sequence.1,2
Rezvoglar has a different amino acid sequence to that of human insulin (Structure of Rezvoglar Compared With Human Insulin).1
Position |
Rezvoglar |
Human Insulin |
A21 |
Glycine |
Asparagine |
C-terminus of the beta chain |
Addition of 2 arginines |
NA |
Abbreviations: NA = not applicable; Rezvoglar = Rezvoglar™ (insulin glargine-aglr) 100 units/mL.
Enclosed Prescribing Information
References
1Rezvoglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
2Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: May 04, 2022